NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 155 filers reported holding NEKTAR THERAPEUTICS in Q1 2015. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $704,000 | +31.1% | 32,667 | +10.7% | 0.00% | 0.0% |
| Q3 2019 | $537,000 | -37.6% | 29,501 | +21.9% | 0.00% | -33.3% |
| Q2 2019 | $861,000 | +24.4% | 24,195 | +17.6% | 0.01% | +20.0% |
| Q1 2019 | $692,000 | +17.5% | 20,580 | +15.0% | 0.01% | 0.0% |
| Q4 2018 | $589,000 | -44.3% | 17,895 | +3.3% | 0.01% | -44.4% |
| Q3 2018 | $1,057,000 | -4.7% | 17,323 | +66.0% | 0.01% | -10.0% |
| Q2 2018 | $1,109,000 | 0.0% | 10,438 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $1,109,000 | +304.7% | 10,438 | +126.8% | 0.01% | +233.3% |
| Q4 2017 | $274,000 | +185.4% | 4,603 | +14.4% | 0.00% | +200.0% |
| Q3 2017 | $96,000 | +17.1% | 4,025 | -3.6% | 0.00% | 0.0% |
| Q2 2017 | $82,000 | -23.4% | 4,175 | -8.7% | 0.00% | 0.0% |
| Q1 2017 | $107,000 | -68.4% | 4,575 | -83.4% | 0.00% | -80.0% |
| Q4 2016 | $339,000 | +370.8% | 27,536 | +565.8% | 0.01% | +400.0% |
| Q3 2016 | $72,000 | +53.2% | 4,136 | +23.6% | 0.00% | 0.0% |
| Q2 2016 | $47,000 | +2.2% | 3,345 | +0.8% | 0.00% | 0.0% |
| Q1 2016 | $46,000 | -41.8% | 3,318 | -29.3% | 0.00% | 0.0% |
| Q4 2015 | $79,000 | +5.3% | 4,693 | -31.2% | 0.00% | -50.0% |
| Q3 2015 | $75,000 | -16.7% | 6,818 | -4.9% | 0.00% | 0.0% |
| Q2 2015 | $90,000 | +13.9% | 7,168 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $79,000 | -11.2% | 7,168 | +24.3% | 0.00% | 0.0% |
| Q4 2014 | $89,000 | +30.9% | 5,768 | +3.0% | 0.00% | 0.0% |
| Q3 2014 | $68,000 | -5.6% | 5,600 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $72,000 | +5.9% | 5,600 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $68,000 | +33.3% | 5,600 | +24.4% | 0.00% | 0.0% |
| Q4 2013 | $51,000 | +34.2% | 4,500 | +25.0% | 0.00% | +100.0% |
| Q3 2013 | $38,000 | +660.0% | 3,600 | +800.0% | 0.00% | – |
| Q2 2013 | $5,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |